Prostaglandin D2 antagonist
US7217725B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2004 |
| Grant date | May 15, 2007 |
| Priority date | — |
| Expiry date | Jul 9, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/422
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is compound 1or a pharmaceutically acceptable salt, or a prodrug thereof. Compound 1 is useful for treating or preventing a variety of diseases or conditions. Results presented herein also demonstrate that Compound 1 is a prostaglandin D2 antagonist, and as such is useful in the treatment or prevention of prostaglandin D2 mediated conditions or diseases.A method comprising administering a prostaglandin D2 antagonist to a mammal suffering from a disease or condition selected from the group consisting of the gastrointestinal tract disorders or diseases, hyperalgesia, allodynia, abdominal cramping, glaucoma, ocular hypertension, and ocular hypotension is also disclosed herein.Pharmaceutical compositions and products comprising compound 1 are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.